icrf 193 has been researched along with ellipticine in 1 studies
| Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (ellipticine) | Trials (ellipticine) | Recent Studies (post-2010) (ellipticine) |
|---|---|---|---|---|---|
| 155 | 0 | 30 | 454 | 0 | 178 |
| Protein | Taxonomy | icrf 193 (IC50) | ellipticine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.0193 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.2 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, VK; Mak, CK; Wong, JT | 1 |
1 other study(ies) available for icrf 193 and ellipticine
| Article | Year |
|---|---|
Type II topoisomerase activities in both the G1 and G2/M phases of the dinoflagellate cell cycle.
Topics: Amsacrine; Animals; Cell Cycle; Chromosomes; Diketopiperazines; Dinoflagellida; DNA Damage; DNA Fragmentation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Ellipticines; Enzyme Inhibitors; Piperazines; Topoisomerase II Inhibitors | 2005 |